Juha Punnonen, M.D., Ph.D. Joins Hinge Bio as Chief Development Officer

Dr. Punnonen joins Hinge Bio with over 20 years of experience as a biopharmaceutical executive and drug developer in the fields of oncology and immuno-oncology BURLINGAME, Calif., May 30, 2023 /PRNewswire/ — Hinge Bio, Inc., a privately-held biotechnology company, today announced that…


ADVERTISEMENT — Advertise With Biotech Networks